BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:MechE Colloquium: Biomedical Device Development for Gastrointestin
 al Applications
DTSTART:20220517T150000
DTEND:20220517T160000
DTSTAMP:20260407T003027Z
UID:5e7c501d984e210375d182d053bfa013aecb05030ee0eb9a7ab59f7b
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Giovanni Traverso\, Department of Mechanical Engineering
 \, Massachusetts Institute of Technology (MIT)\nAbstract: Medication non-a
 dherence (non-compliance) represents a major barrier to effective clinical
  care.  In developed nations\, only 50% of patients take their medication
 s as prescribed\, manifesting in more than $100 billion in avoidable hos
 pitalizations every year in the United States alone and the numbers are f
 ar worse in the developing world.  In his seminar\, Prof. Traverso will p
 resent a series of novel technologies being developed with the goal to en
 hance and facilitate medication administration.  Specifically\, Prof. Tra
 verso will discuss the development of new technologies for the delivery of
  a broad set of drugs including macromolecules through the oral route.\n\n
 Biography: Prof. Traverso is an Assistant Professor in the Department of M
 echanical Engineering at the Massachusetts Institute of Technology and in 
 the Division of Gastroenterology\, Brigham and Women’s Hospital (BWH)\, 
 Harvard Medical School. Prof. Traverso grew up in Peru\, Canada and the Un
 ited Kingdom.  He received his BA from Trinity College\, University of Ca
 mbridge\, UK\, and his PhD from the lab of Prof. Bert Vogelstein at Johns 
 Hopkins University.  He subsequently completed medical school at the Univ
 ersity of Cambridge\, internal medicine residency at the Brigham and Women
 ’s Hospital and his gastroenterology fellowship training at Massachusett
 s General Hospital\, both at Harvard Medical School. Prof. Traverso’s pr
 evious work focused on the development of novel molecular tests for the ea
 rly detection of colon cancer. For his post-doctoral research\, he transit
 ioned to the fields of chemical and biomedical engineering in the laborato
 ry of Professor Robert Langer at the Massachusetts Institute of Technology
  (MIT) where he developed a series of novel technologies for drug delivery
  as well as physiological sensing via the gastrointestinal tract. His curr
 ent research program is focused on developing the next generation of drug 
 delivery systems to enable efficient delivery of therapeutics through the 
 gastrointestinal tract as well developing novel ingestible electronic devi
 ces for sensing a broad array of physiologic and pathophysiologic paramete
 rs. Additionally\, Dr. Traverso continues his efforts towards the developm
 ent of novel diagnostic tests that enable the early detection of cancer.
LOCATION:https://epfl.zoom.us/j/67275071152
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR